GERN
Geron CorporationNASDAQHealthcare$1.66+0.00%ClosedMarket Cap: $1.06B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
4.90
P/S
5.78
EV/EBITDA
-23.71
DCF Value
$-7.80
FCF Yield
-10.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
86.0%
Operating Margin
-29.3%
Net Margin
-46.7%
ROE
-34.2%
ROA
-15.0%
ROIC
-11.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $48.0M | 97.3% | $-10.8M | $-31.1M | $-0.05 | — |
| FY 2025 | $183.9M | 97.4% | $-53.8M | $-85.8M | $-0.13 | — |
| Q3 2025 | $47.2M | 53.2% | $-13.9M | $-18.4M | $-0.03 | — |
| Q2 2025 | $49.0M | 97.6% | $-12.5M | $-16.4M | $-0.02 | — |
| Q1 2025 | $39.6M | 97.0% | $-16.7M | $-19.8M | $-0.03 | — |
| Q4 2024 | $47.5M | 98.4% | $-20.1M | $-25.4M | $-0.04 | — |
| FY 2024 | $77.0M | 98.4% | $-173.7M | $-174.6M | $-0.27 | — |
| Q3 2024 | $28.3M | 98.4% | $-28.2M | $-26.4M | $-0.04 | — |
| Q2 2024 | $882.0K | 98.1% | $-69.3M | $-67.4M | $-0.10 | — |
| Q1 2024 | $304.0K | 100.0% | $-56.1M | $-55.4M | $-0.09 | — |
| Q4 2023 | $23.0K | 100.0% | $-54.3M | $-52.0M | $-0.09 | — |
| FY 2023 | $237.0K | 100.0% | $-193.9M | $-184.1M | $-0.32 | — |